Daping Yu

649 total citations
34 papers, 476 citations indexed

About

Daping Yu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Daping Yu has authored 34 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Daping Yu's work include Lung Cancer Diagnosis and Treatment (11 papers), Tracheal and airway disorders (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Daping Yu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (11 papers), Tracheal and airway disorders (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Daping Yu collaborates with scholars based in China and United States. Daping Yu's co-authors include Yi Han, Xiaoyun Song, Chongyu Su, Shijie Zhou, Yi Han, Xiaoqing Cao, Ning Xiao, Zhidong Liu, Zhidong Liu and Yunsong Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and Journal of Cellular Physiology.

In The Last Decade

Daping Yu

33 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daping Yu China 11 215 190 155 93 42 34 476
Jinlan He China 11 160 0.7× 111 0.6× 99 0.6× 96 1.0× 37 0.9× 24 320
Anna Tanoglidi Sweden 7 318 1.5× 148 0.8× 111 0.7× 115 1.2× 33 0.8× 9 476
Yaoxiong Xia China 13 139 0.6× 133 0.7× 99 0.6× 122 1.3× 31 0.7× 39 348
Fangdie Ye China 13 223 1.0× 154 0.8× 151 1.0× 93 1.0× 52 1.2× 34 395
Hiju Hong China 12 258 1.2× 163 0.9× 123 0.8× 127 1.4× 49 1.2× 22 423
Yang Peng China 13 228 1.1× 204 1.1× 123 0.8× 206 2.2× 29 0.7× 44 485
Hongliang Wu China 12 207 1.0× 126 0.7× 93 0.6× 82 0.9× 34 0.8× 23 395
Hae Min Jeong South Korea 11 174 0.8× 118 0.6× 145 0.9× 167 1.8× 76 1.8× 19 457
Zhiguang Yang China 13 187 0.9× 174 0.9× 134 0.9× 142 1.5× 19 0.5× 40 481
Baoshan Cao China 12 194 0.9× 112 0.6× 137 0.9× 225 2.4× 30 0.7× 67 498

Countries citing papers authored by Daping Yu

Since Specialization
Citations

This map shows the geographic impact of Daping Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daping Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daping Yu more than expected).

Fields of papers citing papers by Daping Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daping Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daping Yu. The network helps show where Daping Yu may publish in the future.

Co-authorship network of co-authors of Daping Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Daping Yu. A scholar is included among the top collaborators of Daping Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daping Yu. Daping Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Liang, Shuhong Gao, Tong Li, et al.. (2023). Pathological complete response to long-course neoadjuvant alectinib in lung adenocarcinoma with EML4-ALK rearrangement: report of two cases and systematic review of case reports. Frontiers in Oncology. 13. 1120511–1120511. 4 indexed citations
2.
Hang, Peng, Wan Zhang, Yankun Li, et al.. (2022). CircFAT1 Promotes Lung Adenocarcinoma Progression by Sequestering miR-7 from Repressing IRS2-ERK-mediated CCND1 Expression. International Journal of Biological Sciences. 18(10). 3944–3960. 4 indexed citations
3.
Zhang, Yushan, et al.. (2021). Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways. Frontiers in Cell and Developmental Biology. 9. 773048–773048. 27 indexed citations
4.
Su, Chongyu, Yi Han, Hongtao Zhang, et al.. (2018). CiRS‐7 targeting miR‐7 modulates the progression of non‐small cell lung cancer in a manner dependent on NF‐κB signalling. Journal of Cellular and Molecular Medicine. 22(6). 3097–3107. 108 indexed citations
5.
Su, Chongyu, Yunsong Li, Yi Han, et al.. (2018). MiR‐21 improves invasion and migration of drug‐resistant lung adenocarcinoma cancer cell and transformation of EMT through targeting HBP1. Cancer Medicine. 7(6). 2485–2503. 41 indexed citations
6.
7.
Liu, Zhidong, et al.. (2016). The clinicopathological significance of <em>hMLH1</em> hypermethylation in non-small-cell lung cancer: a meta-analysis and literature review. OncoTargets and Therapy. Volume 9. 5081–5090. 8 indexed citations
8.
Cai, Yiran, Yujie Dong, Hongbo Wu, et al.. (2016). Expression level of CRKL and AXL combined with exon 19 deletion in EGFR and ALK status confer differential prognosis of lung adenocarcinoma subtypes. Oncology Letters. 12(5). 3312–3322. 1 indexed citations
9.
Han, Yi, Shijie Zhou, Daping Yu, Xiaoyun Song, & Zhidong Liu. (2015). Video-assisted left upper bronchial sleeve lobectomy. ASVIDE. 1(1).
10.
Han, Yi, Shijie Zhou, Daping Yu, Xiaoyun Song, & Zhidong Liu. (2015). VATS left upper sleeve lobectomy with partial pulmonary artery resection. ASVIDE. 1(1). 1 indexed citations
11.
Zhou, Shijie, Yi Han, Daping Yu, et al.. (2015). Sleeve lobectomy by video-assisted thoracic surgery versus thoracotomy for non-small cell lung cancer. Journal of Cardiothoracic Surgery. 10(1). 116–116. 38 indexed citations
12.
Han, Yi, et al.. (2015). Treatment of chest wall tuberculosis with transdermal ultrasound-mediated drug delivery. Experimental and Therapeutic Medicine. 9(4). 1433–1437. 3 indexed citations
13.
Yu, Daping, Jie Li, Yi Han, et al.. (2014). Gene expression profiles of ERCC1, TYMS, RRM1, TUBB3 and EGFR in tumor tissue from non-small cell lung cancer patients. Chinese Medical Journal. 127(8). 1464–1468. 3 indexed citations
14.
Yu, Daping, Yi Han, Shijie Zhou, et al.. (2014). Video-assisted thoracic bronchial sleeve lobectomy with bronchoplasty for treatment of lung cancer confined to a single lung lobe: a case series of Chinese patients. Journal of Cardiothoracic Surgery. 9(1). 67–67. 15 indexed citations
15.
Yu, Daping, et al.. (2014). CD3+CD4+and CD3+CD8+Lymphocyte Subgroups and their Surface Receptors NKG2D and NKG2A in Patients with Non-small Cell Lung Cancer. Asian Pacific Journal of Cancer Prevention. 15(6). 2685–2688. 19 indexed citations
16.
Han, Yi, Li Guo, Chongyu Su, et al.. (2013). Exploratory study on the correlation between 14 lung cancer-related gene expression and specific clinical characteristics of NSCLC patients. Molecular and Clinical Oncology. 1(5). 887–893. 6 indexed citations
17.
Han, Yi, Shijie Zhou, Daping Yu, Xiaoyun Song, & Zhidong Liu. (2013). Video-assisted left upper bronchial sleeve lobectomy.. PubMed. 5 Suppl 3. S304–6. 1 indexed citations
18.
Yu, Daping, et al.. (2013). Pulmonary Lobectomy Combined with Pulmonary Arterioplasty by Complete Video-assisted Thoracic Surgery in Patients with Lung Cancer. Asian Pacific Journal of Cancer Prevention. 14(10). 6061–6064. 15 indexed citations
19.
Yu, Daping, et al.. (2009). [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].. PubMed. 31(6). 465–8. 1 indexed citations
20.
Yu, Daping, et al.. (2009). [Surgical treatment of 133 cases of multi-drug-resistant pulmonary tuberculosis].. PubMed. 32(6). 450–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinlan He Breakdown of academic impact, for papers by Anna Tanoglidi Breakdown of academic impact, for papers by Yaoxiong Xia Breakdown of academic impact, for papers by Fangdie Ye Breakdown of academic impact, for papers by Hiju Hong Breakdown of academic impact, for papers by Yang Peng Breakdown of academic impact, for papers by Hongliang Wu Breakdown of academic impact, for papers by Hae Min Jeong Breakdown of academic impact, for papers by Zhiguang Yang Breakdown of academic impact, for papers by Baoshan Cao
Rankless by CCL
2026